• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7213
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 06/17/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that stenosis occurred.The target lesion was 10 mm long with a reference vessel diameter of 2.0 mm and located in the mid left anterior descending artery.The subject was on a prior regimen of aspirin and antiplatelet medications other than aspirin.A loading dose of 243 mg of aspirin was given prior to the procedure.Pre procedure angiogram noted 55% side branch stenosis of the first diagonal with a thrombolysis in myocardial infarction (timi) flow of 3.Heparin or other antithrombotic medication were administered at the time of procedure.The lesion was pre dilated with a 3.0 mm x 15 mm balloon with 5% residual stenosis and timi flow of 3.A 3.0 mm x 15 mm nc emerge was deployed successfully with 10% residual stenosis and timi flow 3.Post procedure angiogram noted 80% side branch stenosis of the first diagonal with a timi flow of 3.The subject was discharged with aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16354786
Report Number2124215-2023-04926
Device Sequence Number15183016
Product Code LOX
UDI-Device Identifier08714729846529
UDI-Public08714729846529
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/28/2024
Device Model Number7213
Device Catalogue Number7213
Device Lot Number0028950259
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/18/2023
Initial Report FDA Received Date02/10/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age65 YR
Patient SexMale
Patient RaceWhite
-
-